Hyperoxia is implicated in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of premature infants. High levels of supplemental oxygen can result in microvascular endothelial cell death and may disrupt lung development. In postnatal animals, hyperoxia inhibits expression of vascular endothelial growth factor (VEGF), which is required for normal vascular development. A potential mechanism of oxygen effects on VEGF is induction of p53, a transcription factor that represses VEGF gene transcription. Oxidant DNA damage can increase p53. We used a moderately premature baboon model of hyperoxia to examine p53, oxidant DNA damage, and VEGF expression. Fetal baboons delivered at 140 d of gestation (75% of term) were ventilated with 100% oxygen or oxygen as needed for 6 or 10 d. Lungs from the 10-d 100% oxygen animals had increased nuclear p53, compared with the oxygen as needed animals. The mechanism of increased p53 was probably related to oxidant DNA damage, which was documented by increased oxidized guanine. Dual fluorescent confocal microscopy found increased oxidized guanine in mitochondrial DNA of distal lung epithelial cells. Distal epithelial cell VEGF expression was decreased and p21, another downstream target of p53, was increased in the distal epithelium of the hyperoxic animals. These data show that p53 is induced in hyperoxic fetal lung epithelium and are consistent with p53 repression of VEGF expression in these cells. The findings suggest that oxidant DNA damage may be a mechanism of increased p53 in hyperoxic fetal lung. Premature newborns with immature lungs often need high levels of inspired oxygen, which is toxic to alveolar epithelial and endothelial cells (1) . Hyperoxia may be a causal factor in the development of BPD, a chronic lung disease of premature newborns that has significant morbidity. Human infants with BPD have impaired alveolization and disrupted development of the alveolar microvasculature (2, 3) . Premature nonhuman primates treated with sufficient oxygen and ventilation to maintain normal arterial blood gases also had abnormal alveolar and microvascular development (4, 5) . Although premature infants are frequently treated with supplemental oxygen, the effects of hyperoxia on the fetal lung are poorly understood.
In postnatal lung, hyperoxia has diverse deleterious effects, including decreased expression of lung VEGF (6 -8) . Pulmonary VEGF was decreased in various clinical lung injuries in which oxygen therapy was used, including ARDS, sepsis, and BPD (3, 9, 10) . VEGF has multiple roles in vascular development and maintenance and is essential for formation of the embryonic vasculature, as demonstrated by embryo lethality of VEGF heterozygous null mutants (11) . In fetal lung in the late canalicular stage, VEGF was expressed mainly by distal airspace epithelial cells and its expression increased during lung development (5, 12, 13) . Absence of key VEGF isoforms, which are the products of alternative mRNA splicing, resulted in impaired fetal lung microvascular development (14) . Withdrawal of VEGF resulted in endothelial cell death, suggesting that VEGF may also be a survival factor for endothelial cells (15, 16) . The mechanisms of decreased VEGF expression in hyperoxia are not known, but VEGF is strongly induced by HIF-1, a transcription factor that is expressed in hypoxic conditions (17) .
Hyperoxic damage to cells results from reactive oxygen species (ROS) interaction with macromolecules such as DNA, lipids and proteins. For DNA, the damage consists of strand breaks, base modifications, sister chromatid exchanges and oxidation of guanine to 8-oxoG. Detecting DNA with 8-oxoG can identify cells with oxidant DNA damage (18 -20) . Oxidized guanine is found in damaged DNA in both nuclei and mitochondria (21) . Oxidant injury of tissues may be exacerbated by impaired VEGF signaling. VEGF induces MnSOD and nitric oxide, which are both involved in scavenging ROS (22, 23) .
A potential mechanism that may regulate VEGF expression in hyperoxic lung injury is increased p53, which can be induced by DNA damage. A multifunctional transcription factor, p53 is increased in hyperoxic injury of adult murine lung (24) . Multiple lung cell types, including alveolar epithelial cells, express p53 in vivo after hyperoxia. VEGF transcription is decreased by p53 in vitro and in vivo (25) (26) (27) (28) . The mechanism of p53 inhibition of VEGF expression involves HIF-1 and Sp-1, transcription factors that regulate VEGF gene transcription (25, 29) . Very little is known about p53 in lung development, but it may be related to differentiation of the normal alveolar epithelium (30) . In oxidant lung injury, p53 may inhibit cell proliferation by induction of p21 CIP1/WAF1 (hereafter p21) to allow repair of DNA damage (31) . Expression of p53 is also characteristic of endothelial cells that are apoptotic (32, 33) . Although lung p53 is induced in adult rodent hyperoxic injury, it is not known whether p53 is induced in hyperoxic injury of developing lung. The cell-specific correlation of p53 with VEGF expression or oxidant DNA damage is also not known.
To investigate the effects of hyperoxia on p53, oxidant DNA damage and VEGF expression, we used a well-described model of moderately premature baboons delivered at 140 d of gestation (75% of term) that were treated with ventilation and either 100% oxygen or oxygen as needed (PRN oxygen) for up to 10 d. Baboons treated with 100% oxygen are known to have decreased endothelial cells (34) . We hypothesized that ventilation of these animals with 100% oxygen would result in oxidant DNA damage, increased p53, and decreased VEGF expression.
MATERIALS AND METHODS
Animals and hyperoxia exposure. The Southwest Foundation for Biomedical Research (San Antonio, TX) provided baboon lung samples. All animal procedures were reviewed and approved by the Animal Association for Accreditation of Laboratory Animal Care guidelines. Gestational controls were delivered by hysterotomy at 140 Ϯ 2 d, 146 Ϯ 2 d and 160 Ϯ 2 d gestation. Some baboons delivered at 140 Ϯ 2 d were treated with standardized protocols as detailed previously (35, 36) . These animals were intubated, placed on a ventilator and treated with either PRN (pro re nada) oxygen to maintain PO 2 between 50 and 80 mm Hg or 100% oxygen continuously. In both groups, mechanical ventilation was adjusted to maintain PCO 2 between 35 and 55 mm Hg. Surfactant replacement was not administered. The animals were killed at 6 d and 10 d. In the PRN group, the mean FIO 2 was ϳ 0.60 for the first 48 h and then declined to ϳ 0.23 by 80 h of age. The FIO 2 remained at this level for the remaining study time. At necropsy the lungs were inflation fixed by instillation of 4% paraformaldehyde in 0.1 mol/L phosphate buffer at 20 cm H 2 O and tissue blocks were embedded in paraffin and sectioned.
Immunohistochemistry and confocal microscopy. Primary antibodies used were mouse monoclonal anti-human p53 (Ab-6, clone DO-1, Oncogene Research Products, San Diego, CA), Alexa-594 conjugated mouse monoclonal anti-cytochrome oxidase subunit 1 antibody (clone 1D6, Molecular Probes, Eugene, OR) and mouse monoclonal anti-human p21 antibody (clone SX-118, B. D. PharMingen, San Diego, CA). The anti-p53 DO-1 clone reacts with total p53. The secondary antibody was biotinylated horse anti-mouse IgG (Vector Labs, Burlingame, CA). Control antibodies were nonimmune monoclonal mouse IgG.
After removal of paraffin, the lung sections were rehydrated through graded ethanol washes and rinsed in deionized water. Antigen retrieval was performed by heating the slides in 50 mmol/L Tris pH 10 for 15 min, followed by cooling at 25°C for 20 min. Slides were treated with 1% hydrogen peroxide in methanol and rinsed in water. Slides were rinsed in 50 mmol/L Tris 150 mmol/L NaCl pH7.5 (TBS) and then blocked with 3% horse serum in TBST (TBS ϩ 0.05% Tween 20) . Slides were incubated for 3 h in anti-p53 antibody or anti-p21 antibody (1:50 in TBS ϩ 2% horse serum), rinsed in TBS, incubated 45 min with biotinylated horse anti-mouse IgG (1:200), rinsed, treated for 30 min with Vectastain ABC Elite, rinsed, and stained with DAB substrate (Vector Labs).
Staining for 8-oxoG was performed using an OxyDNA assay kit (Calbiochem, San Diego, CA). Briefly, sections were deparaffinized and rehydrated through graded ethanols before subjecting to antigen retrieval by simmering in 50 mmol/L Tris pH 9.5 for 10 min. Sections were permeabilized with methanol at Ϫ20°C, blocked and incubated overnight with FITC-conjugated 8-oxoG binding protein at 4°C. Sections were washed extensively, immersed in DAPI, and visualized with a Nikon E800 fluorescence microscope. Images were captured with a SPOT-RT digital camera. When co-staining for mitochondria, sections were co-incubated overnight with 8-oxoG and Alexa-594 conjugated mouse anti-cytochrome oxidase subunit 1 antibody. These sections were not treated with DAPI but were scanned with a Leica TCS SP Spectral Confocal microscope, equipped with an upright DMRXE.
Western immunoblot. Frozen lung tissue was homogenized and the proteins (50 g) were separated by SDS-PAGE and transferred to polyvinylpyrrolidone fluoride membrane as described (5) . The membranes were blocked for 1 h at room temperature in phosphate-buffered saline (PBS) containing 5% nonfat dry milk plus 0.05% Tween 20 (PBST). The membranes were then incubated overnight at 4°C in primary anti-p53 antibody (1:1000, Oncogene Research Products, Cambridge, MA) followed by three washes in PBS to remove nonspecific interactions. Membranes were then incubated in secondary antibody (goat anti-mouse; Southern Biotechnology, Birmingham, AL) for 1 h at room temperature. After washing the membranes with PBST, specific antibody interactions were visualized by chemiluminescence (Amersham, Arlington Heights, IL). As a loading control, membranes were also blotted for ␤-actin (1:5000; Sigma Chemical Co., St. Louis, MO). The data are expressed as the ratio of p53 to ␤-actin.
In situ hybridization. Cell-specific location of VEGF mRNA was conducted as detailed previously (5, 6) . The VEGF cDNA is 94% homologous to human VEGF and hybridizes to all VEGF mRNA splice variants. Briefly, lung tissue sections on TES-treated slides were treated with proteinase K and equilibrated in triethanolamine (pH 8.0) and acetic anhydride. Prehybridization was at 55°C for 2 h. Hybridization was performed at 53°C using 33 P-labeled sense or anti-sense probes. After hybridization, the slides were rinsed and digested with RNases, and stringent washes were performed in 0.1ϫ salinesodium citrate (SSC) at 64°C. The slides were dipped in NTB-2 emulsion and exposed at 4°C.
Ribonuclease protection assay. These assays were performed as described previously (5) . Briefly, lung tissues were lysed in 4 mol/L guanidinium isothiocyanate, 0.5% N-lauryl sarcosine, and 25 mmol/L sodium citrate, and stored at -80°C. Total cell RNA was extracted by standard methods. The ribonuclease protection assays were performed with commercial reagents and protocols (Riboquant; PharMingen). Radiolabeled, single-strand RNA probes for VEGF, VEGFR-1, and L32 were synthesized using T7 polymerase. RNA samples, including human RNA and yeast transfer RNA (2 g) as positive and negative controls, were dried and resuspended in hybridization buffer and radiolabeled probe. The samples were denatured at 90°C and incubated overnight at 56°C. Single-stranded RNA was digested in Rnase A/T1 followed by proteinase K digestion. The remaining radiolabeled RNA fragments were resolved on a 6% acrylamide/urea gel, using radiolabeled probe as size markers. The gels were dried and quantified by phosphorimaging. Data for VEGF and VEGFR-1 are expressed relative to L32, a ribosomal protein.
VEGF mRNA splice variant analysis. VEGF mRNA splice variants were analyzed by reverse transcriptase polymerase chain reaction as described previously (5, 37) . Briefly, primers located in VEGF exons 5 and 8 were used to amplify the splice variants (VEGF 189 , VEGF 165 , and VEGF 121 ) in the presence of [ 32 P]dCTP. Amplified products were separated on highly denaturing polyacrylamide gels and quantified by phosphorimaging and image analysis. To account for differences in signal intensity due to the differences in splice variant sizes, the data are expressed as molar ratios.
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RESULTS
Hyperoxic injury increases lung p53 expression.
Lungs from gestational controls and animals treated with PRN oxygen or 100% oxygen for 6 and 10 d were immunostained with antibody against total p53 (Fig. 1) . Gestational controls at 140 and 146 d had occasional cell nuclei that stained for p53 ( Fig.  1A and B) . Compared with the gestational controls, the 6-d PRN oxygen animals had increased staining of nuclei that were mainly in thickened inter-airspace septa (Fig. 1C, arrow) . By contrast, the animals treated with 100% oxygen for 6 d had substantially increased nuclei that stained for p53 (Fig. 1D,  arrow) . A similar increase in p53-positive nuclei was noted in the 10-d 100% oxygen animals compared with the 10d PRN oxygen group (Fig. 1E and F) . Very little cytoplasmic staining was noted. In both 100% oxygen-treated groups, a broad range of cell types had nuclei that contained p53, including distal airspace epithelial cells and mesenchymal cells in the interairspace septa. With these methods we could not identify the specific mesenchymal cells that had increased p53. Macrophages in the alveolar spaces often had p53-stained nuclei (arrowheads, Fig. 1D ). Sections incubated with control antibody had minimal staining (Fig. 1D, insert) .
Increased p53 protein in hyperoxic lung. Western immunoblotting for total p53 ( Fig. 2A and B) showed relatively little expression of the protein in the 140-d gestational controls and the 6-d PRN oxygen animals. The 6-d 100% oxygen animals had increased p53 protein, but the quantification did not reach statistical significance. Compared with the 10-d PRN animals, however, the 10-d 100% oxygen animals had a significant increase in p53 protein relative to actin (p ϭ 0.02), confirming the qualitative findings on immunohistochemistry. At higher concentrations, p53 protein ran as a doublet ( Fig. 2A) , which might be due to proteolytic processing of the native protein.
The antibody used for this analysis detects total p53. It has been widely used by us and others (24) and identified no significant nonspecific bands on Western analysis.
Increased 8-oxoG in hyperoxic lung. Increased expression of p53 may result from oxidant DNA damage, which can be detected by identification of 8-oxoG, an oxidation product of guanine. We used a fluorescent peptide that binds specifically to 8-oxoG in both nuclear and mitochondrial DNA. Very little binding of 8-oxoG, noted as green (FITC) signal, was found in gestational control lungs ( Fig. 3A and B) , suggesting minimal nonspecific binding of the peptide. In the 140-d 6-d PRN oxygen lungs, fine speckles of green are noted in scattered parenchymal cells (Fig. 3C) . The 140-d 6-d 100% oxygen lungs (Fig. 3D) had increased 8-oxoG signal in parenchymal cells (arrows), including distal epithelial and mesenchymal (Fig. 3E) , but substantially increased perinuclear signal was noted in the 10-d 100% oxygen animals, particularly in the distal epithelial cells (Fig. 3F, arrows) . The perinuclear localization of 8-oxoG in the hyperoxic animals suggested that it was in mitochondrial DNA. This was confirmed by dual fluorescent microscopy for 8-oxoG and the mitochondrial marker cytochrome oxidase subunit 1 (Fig. 4) . Confocal microscopy of 140-d 10-d 100% oxygen lung confirmed the perinuclear localization of 8-oxoG signal (Fig. 4A) . Similarly, anticytochrome oxidase subunit 1 antibody binding was also perinuclear (Fig. 4B) . Combining the confocal images (Fig. 4C) showed extensive perinuclear yellow signal of the hyperoxic lung, suggesting oxidant damage in mitochondrial DNA.
Increased p21 immunostaining in hyperoxic lung. In addition to repressing VEGF expression, p53 can induce p21, which results in cell cycle arrest in G1 (38) . Finding increased p21 in hyperoxic lung injury would support functional activation of p53 in hyperoxia. To determine whether p21 was expressed, we identified the protein by immunostaining in 140 d gestational controls and in 6-and 10-d PRN oxygen and hyperoxic animals. Gestational controls had occasional cells with p21-positive nuclei (not shown). The 6-d PRN oxygen animals had some p21-positive nuclei (Fig. 5A) , which appeared to decrease in the 10-d PRN oxygen animals (Fig. 5C) . However, both 6-and 10-d hyperoxic animals had substantial nuclear staining for p21 compared with the PRN animals ( Fig.  5B and D) . Similar to p53, p21-positive nuclei were found in both distal airspace epithelial cells and interairspace mesenchymal cells, although it appeared more common in epithelial cells. The control antibody gave minimal staining (insert, Fig.  5D ). These data are consistent with an increase in functional p53 in hyperoxic fetal lung.
Decreased VEGF in hyperoxic lung. Because p53 may regulate the expression of VEGF, we examined message for VEGF in lungs from PRN and hyperoxic animals (Fig. 6) . By RPA, VEGF mRNA was not different between the 6-d PRN oxygen animals and the 6-d 100% oxygen animals. However, by 10 d of 100% oxygen, VEGF mRNA levels were signifi- cantly decreased compared with the 10d PRN animals ( Fig.  6B ; p ϭ 0.02). Because decreased VEGF signaling may increase oxidant stress, we examined the message for the VEGF receptor VEGFR-1 (Flt-1). There were no differences in VEGFR-1 expression in the hyperoxic animals compared with the controls (Fig. 6C) . Alternative splicing of VEGF mRNA produces three main splice variants (VEGF 121 , VEGF 165 , and VEGF 189 ) that are translated into three isoforms with differing mitogenic effects on endothelial cells. We have documented previously in postnatal rabbit lung that hyperoxic lung injury alters the relative expression of these splice variants (37) . In fetal baboon lungs exposed to hyperoxia, however, we found no changes in the molar ratios of the VEGF splice variants (Fig. 7) .
Decreased VEGF mRNA in distal airspace epithelial cells in hyperoxic lung. In late fetal lung from baboon and other species, VEGF mRNA is found mainly in distal epithelial cells that resemble type II cells (5, 12, 13) . In situ hybridization for VEGF in 10-d PRN oxygen animals ( Fig. 8A and B) found a distribution of VEGF mRNA that was concentrated in individual cells in the distal epithelium. The mesenchyme of the interairspace septa also had signal above background, but minimal grains were noted in conducting airway epithelium or large blood vessel endothelial cells. These findings are similar to previously reported data on cell-specific VEGF expression in normal fetal baboon lung (5). In the 10-d 100% oxygen animals, however, there was a marked decrease in the expression of VEGF by distal epithelial cells (Fig. 8C) . The injury was heterogeneous, however, and some areas of lung had VEGF expression that was similar to the PRN animals (not shown). The sense probe hybridization had minimal grains (Fig. 8D) . These data suggest that hyperoxia and increased p53 are associated with decreased VEGF expression in fetal lung distal airspace epithelial cells.
DISCUSSION
Exposure to increased inspired oxygen is mechanistically linked to the development of chronic lung disease in premature infants. In developing lung, hyperoxia results in epithelial and endothelial cell loss, disordered proliferation, and other changes that may impede alveolar and microvascular develop- 553 ment (34, 39, 40) . As shown in this and other studies, severe hyperoxia can decrease lung VEGF expression (6 -8) , which may disrupt microvascular development. VEGF may also be required for normal lung epithelial differentiation (41) . The mechanism of decreased VEGF expression in hyperoxia is not known. Recent data suggest that the transcription factor p53 is increased in hyperoxic lung injury by phosphorylation of serine-15 to produce a stable isoform that is transcriptionally active (24) . VEGF mRNA is decreased by p53 through mechanisms involving Sp-1 and HIF-1 (25, 27, 29) . We found increased p53 in distal lung epithelial cells of hyperoxic fetal baboon lung, which correlated with decreased VEGF expression in these cells. These data are consistent with a role for p53 in regulating VEGF. Further, we showed that hyperoxic fetal baboon lung had evidence of oxidant DNA injury in distal epithelial cells, identified by increased mitochondrial 8-oxoG. These data support oxidant DNA damage as a mechanism of increased p53 in this model.
In normal fetal lung development, VEGF message becomes abundant in distal epithelial cells that resemble type II cells (12, 13) . The mechanism of epithelium-specific VEGF expression is not known but might be linked to normal type II cell proliferation and differentiation. Disrupted epithelial development, which is characteristic of BPD, is associated with decreased VEGF and an abnormal microvasculature (3, 5, 42) . Blockade of VEGF receptor-2 (VEGFR-2) resulted in impaired vascular development and alveolization (43) , suggesting that normal vascularization is required for normal alveolization. VEGF is also a survival factor for endothelial cells and VEGF withdrawal results in endothelial cell death (44) . We did not quantify endothelial cells in our study, but Coalson et al. (34) found decreased endothelial cells in 140-d gestation baboons after 11 d of 100% oxygen compared with animals treated with PRN oxygen.
Although several studies have shown decreased VEGF expression in hyperoxia (6, 7, 15) , the mechanism is not known. The present study supports a role for p53 in decreased VEGF mRNA. By forming a complex with the transcription factor Sp-1, p53 may inhibit VEGF expression by preventing Sp-1 binding to the VEGF promoter and abrogating Sp-1 induction of VEGF transcription (25, 27) . Another mechanism of p53 effects on VEGF involves HIF-1. The VEGF promoter contains binding sites for HIF-1, a transcription factor that induces VEGF expression in hypoxic conditions (17, 45) . p53 binds to HIF-1 and promotes proteosomal destruction of the HIF-1␣ subunit (29) . The role of HIF-1 in VEGF expression in fetal or postnatal lung is not known, but null mutants of a related factor, HIF-2, had decreased VEGF and disrupted lung development (41) . Tumor cells with mutant p53 have high VEGF expression, and loss of p53 enhances HIF-1 induction of VEGF (29, 46) . Increasing p53 by transfection or in temperaturesensitive mutants decreased VEGF expression by transcriptional mechanisms (25, 27, 28, 47) . Decreased VEGF in hyperoxia is interesting because normal ROS signaling mechanisms can induce VEGF in vitro (48) . Our findings of increased p53 and decreased VEGF mRNA in distal epithelial cells are consistent with p53 regulation of VEGF in hyperoxia.
The splice variant VEGF 121 was relatively more abundant in the PRN oxygen and hyperoxic baboons than VEGF 165 or VEGF 189 . This differs from late-gestation normal fetal rabbits but is similar to normal fetal mice (14, 37) . Contrary to previous studies in hyperoxic neonatal rabbits (37), we found no major changes in the VEGF mRNA splice variant patterns in hyperoxic baboons compared with PRN oxygen animals. This might be related to species and age differences in the studies (fetal baboon versus neonatal rabbit). Although VEGF isoforms differ in their extracellular matrix binding and mitogenic potential, the significance of changes in their relative expression is unknown.
The mechanism of increased p53 in hyperoxic baboon lung may be related to oxidant-induced DNA damage. ROS can oxidize DNA, particularly at guanine residues, resulting in DNA strand breaks. We documented oxidant DNA damage in 100% oxygen-treated animals by detecting the DNA oxidation product 8-oxoG. Increased lung 8-oxoG was recently found in neonatal rats exposed to hyperoxia (19) . Using confocal microscopy and an antibody to the mitochondrial protein cytochrome oxidase subunit 1, we localized 8-oxoG to mitochondria. Little 8-oxoG was detected in nuclei. Recent studies show that mitochondrial DNA is three times more sensitive to oxidant injury than nuclear DNA (21) , possibly related to mitochondria as a primary source of ROS. Mitochondrial DNA also lacks chromatin, which may protect DNA from oxidant injury. Our finding of mitochondrial rather than nuclear DNA damage may reflect greater oxidant injury to mitochondrial DNA or a limited sensitivity of the 8-oxoG detection methods. Documenting nuclear DNA damage by other techniques, such as comet assays, is not feasible with the lung samples obtained from these animals. In adult mice treated with 100% oxygen, we found increased mitochondrial 8-oxoG that correlated with nuclear DNA strand breaks, measured by comet assays (20) . However, the current studies cannot prove oxidant damage to nuclear DNA.
As shown by our data, p53 has relatively low expression in normal developing lung. Although p53 null mutant mice have no apparent pulmonary defects, p53 has been linked to the differentiation of the distal airspace epithelium (30) . In adult mice, hyperoxia induces alveolar epithelial p53 expression (24) . In hyperoxic injury, p53 accumulates by posttranscriptional mechanisms, including phosphorylation of serine-15, which increases stability of the protein (24) . In the present study, we found an increase in total p53, which likely represents an increase in the serine-15 phosphorylated species.
A significant role of p53 in oxidant lung injury may be to allow DNA repair. Cells with increased p53 transiently arrest in G1 to permit DNA repair or to enter the apoptotic pathway if the DNA damage is severe. The growth-inhibitory effects of p53 are mediated by induction of p21, a cyclin-dependent kinase inhibitor (49) . In adult rodents, lung p21 is also induced by hyperoxia, although the mechanisms are both p53 dependent and independent (38) . Because p53 can regulate cell cycle progression, apoptosis, Sp-1 binding, and HIF-1 stability, it may be central to multiple lung cell responses to hyperoxia.
The present study showed that several cell types had 8-oxoG and expressed p53 in the hyperoxic fetal lung, including both 554 VEGF AND DNA DAMAGE IN HYPEROXIA epithelial and mesenchymal cells. Increased epithelial p53 may decrease VEGF expression in those cells. Although our data cannot identify the mesenchymal cells that express these factors, both p53 and p21 are increased in endothelial cells undergoing apoptosis in vitro (33, 50) . LPS-treated endothelial cells have increased p53 expression and become apoptotic, which can be prevented by pretreatment with VEGF (32) .
This study has certain important limitations. The model of premature baboons closely mimics the clinical scenario of hyperoxic injury to developing, ventilated human lungs. The data are correlative and cannot define precise mechanisms, but they are important to support or refute hypotheses directly relevant to a complex lung disease. The model is very useful in documenting the effects of clinically relevant interventions, such as hyperoxia, on complex processes, such as fetal lung vascular and epithelial development. As groups, the PRN oxygen and hyperoxic animals differed somewhat in their ventilator settings by 10 d, with the hyperoxic animals requiring a higher mean airway pressure to maintain normal arterial blood gases (36) . The contribution of this difference to our findings is not known, but our data are consistent with hyperoxic induction of DNA damage, p53, and decreased VEGF seen in nonventilated models (6, 20, 24) . We did not examine changes in vascular development coincident with alterations in VEGF, p53, or p21. However, previous investigators have documented decreased endothelial cells in this model (34) . Hyperoxic lung injury and BPD are somewhat heterogeneous and some areas of the lung in our studies appear relatively normal. However, quantifying p53 protein and VEGF mRNA confirmed the immunohistochemical and in situ hybridization studies.
In summary, exposure to 100% oxygen resulted in oxidant DNA damage, increased p53, and decreased VEGF expression in fetal baboon lungs. Increased epithelial p53 expression is a potential mechanism of decreased VEGF expression. Oxidant DNA damage, identified by increased 8-oxoG, may be a mechanism of increased p53 in hyperoxic injury. Other potential roles for p53 in hyperoxic injury may be as a mediator of cell cycle arrest and endothelial cell death. These responses to hyperoxia are likely to have deleterious effects on lung development.
